Atossa Genetics Inc (ATOS) — Cash Flow-to-Debt Ratio
Atossa Genetics Inc (ATOS) has a Cash Flow-to-Debt Ratio of -0.73x as of September 2025, meaning its operating cash flow of $-6.00 Million could theoretically repay -1% of its total liabilities ($8.22 Million) in one year. See ATOS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Atossa Genetics Inc Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Atossa Genetics Inc across 16 annual periods. Also explore Atossa Genetics Inc (ATOS) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Atossa Genetics Inc (2009–2024)
Year-by-year debt coverage analysis for Atossa Genetics Inc. For market capitalisation and broader financial context, see ATOS market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.23x | $-21.03 Million | $4.97 Million | ▼ -5.9% |
| 2023 | -4.00x | $-20.94 Million | $5.24 Million | ▼ -7.3% |
| 2022 | -3.73x | $-20.76 Million | $5.57 Million | ▲ +29.2% |
| 2021 | -5.27x | $-16.47 Million | $3.13 Million | ▼ -613.9% |
| 2020 | -0.74x | $-11.57 Million | $15.68 Million | ▲ +89.1% |
| 2019 | -6.79x | $-9.13 Million | $1.34 Million | ▼ -120.9% |
| 2018 | -3.07x | $-8.96 Million | $2.92 Million | ▲ +42.9% |
| 2017 | -5.38x | $-6.59 Million | $1.23 Million | ▼ -4.9% |
| 2016 | -5.13x | $-5.37 Million | $1.05 Million | ▲ +8.0% |
| 2015 | -5.58x | $-13.95 Million | $2.50 Million | ▼ -19.7% |
| 2014 | -4.66x | $-10.56 Million | $2.27 Million | ▲ +25.8% |
| 2013 | -6.27x | $-8.83 Million | $1.41 Million | ▼ -165.5% |
| 2012 | -2.36x | $-3.90 Million | $1.65 Million | ▼ -2.3% |
| 2011 | -2.31x | $-3.49 Million | $1.51 Million | ▼ -459.0% |
| 2010 | -0.41x | $-358.11K | $866.86K | ▲ +70.4% |
| 2009 | -1.40x | $-75.18K | $53.78K | — |